وبلاگ بلیان

Drug Treatment of Sleep Disorders (Milestones in Drug Therapy)

معرفی کتاب «Drug Treatment of Sleep Disorders (Milestones in Drug Therapy)» نوشتهٔ Antonio Guglietta (eds.)، منتشرشده توسط نشر Springer International Publishing : Imprint Springer در سال 2015. این کتاب در 94 صفحه، فرمت epub، زبان انگلیسی ارائه شده است.

Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders. Front Matter....Pages i-viii Front Matter....Pages 1-1 An Overview of Sleep Physiology and Sleep Regulation....Pages 3-23 Neuronal Networks Regulating Sleep and Arousal: Effect of Drugs....Pages 25-70 Classification of Sleep Disorders....Pages 71-83 Development of New Therapeutical Agents for Treatment of Insomnia and Other Sleeps Disorders....Pages 85-107 Front Matter....Pages 109-109 Low-Dose Doxepin for Insomnia....Pages 111-119 Lorediplon: A New GABA A Modulator Drug for Treatment of Insomnia....Pages 121-145 Zolpidem Sublingual Formulations....Pages 147-157 Eszopiclone: Review and Clinical Applications in Chronic and Comorbid Insomnia....Pages 159-189 Orexin/Hypocretin Antagonists in Insomnia: From Bench to Clinic....Pages 191-207 Front Matter....Pages 209-209 Modafinil and Armodafinil....Pages 211-229 Sodium Oxybate (Xyrem ® ): A New and Effective Treatment for Narcolepsy with Cataplexy....Pages 231-248 Cell Therapy to Treat Narcolepsy....Pages 249-258 Front Matter....Pages 259-259 Tasimelteon....Pages 261-269 Front Matter....Pages 271-271 The Past, Present, and Future of Drug Development and Treatment in Sleep Disorders....Pages 273-288 Back Matter....Pages 289-297 3.1.3 Sleep-Promoting GABAergic ActivatorsGABAA Receptor Agonists; GABAA Receptor Modulators; GABAB Receptor Agonists; GABA Reuptake Inhibitors; 3.1.4 Wake-Promoting GABAergic Inhibitors; GABAA Receptor Antagonists; Benzodiazepine Receptor Antagonists; GABAB and GABAC Receptor Antagonists; GABA Receptor Autoantibodies; 3.2 Melanin Concentrating Hormone; 3.2.1 The MCHergic Sleep-Promoting System; 3.2.2 Wake-Promoting MCH Inhibitors; 3.3 Galanin; 3.3.1 The Galaninergic Sleep-Promoting System; 3.3.2 Sleep-Promoting Galanin Receptor Agonists; 3.3.3 Wake-Promoting Galanin Receptor Antagonists 3.4 Melatonin3.4.1 The Melatoninergic Sleep-Promoting System; 3.4.2 Sleep-Promoting Melatoninergic Activators; 3.4.3 Chronobiotic Melatoninergic Activators; 3.4.4 Wake-Promoting Melatoninergic Inhibitors; 3.5 Adenosine; 3.5.1 The Adenosine-Mediated Sleep-Promoting System; 3.5.2 Adenosine Receptors; 3.5.3 Sleep-Promoting Adenosine Receptor Agonists; 3.5.4 Wake-Promoting Adenosine Receptor Antagonists; 4 Drugs Interacting with Wake-Promoting Systems; 4.1 Histamine; 4.1.1 The Histaminergic Wake-Promoting System; 4.1.2 Histamine Receptors; 4.1.3 Wake-Promoting Histaminergic Activators H1 Receptor AgonistsH3 Receptor Antagonists; 4.1.4 Sleep-Promoting Histaminergic Inhibitors; H1 Receptor Antagonists; H3 Receptor Agonists; 4.2 Orexin; 4.2.1 The Orexinergic Wake-Promoting System; 4.2.2 Narcolepsy: An Orexin-Deficiency State; 4.2.3 Wake-Promoting Orexinergic Activators; 4.2.4 Sleep-Promoting Orexinergic Inhibitors; 4.3 Glutamate; 4.3.1 The Glutamatergic Wake-Promoting System; 4.3.2 Glutamate Receptors; 4.3.3 Wake-Promoting Glutamatergic Activators; 4.3.4 Sleep-Promoting Glutamatergic Inhibitors; 4.3.5 REMS-Suppressing Glutamatergic Inhibitors; 4.4 Acetylcholine 3.5 Autonomic and Cardiovascular Functions3.6 Thermoregulation and Metabolism; 4 Sleep Evolution and Sleep Functions; 4.1 Sleep Phylogenesis; 4.2 Effects of Sleep Deprivation; 4.3 Sleep and Memory; 4.4 Theories of Sleep Functions; References; Neuronal Networks Regulating Sleep and Arousal: Effect of Drugs; 1 Introduction; 2 Neuronal Networks Regulating Sleep and Arousal; 2.1 Sleep/Arousal Network; 2.2 REM-Sleep Network; 2.3 Circadian Network; 3 Drugs Interacting with Sleep-Promoting Systems; 3.1 GABA; 3.1.1 The GABAergic Sleep-Promoting System; 3.1.2 GABA Receptors Preface; Contents; Part I: General Concepts; An Overview of Sleep Physiology and Sleep Regulation; 1 Neurophysiology and Neurobiology of Sleep; 1.1 What Is Sleep?; 1.2 Sleep Architecture; 1.3 Sleep Mechanisms; 2 Sleep Regulation; 2.1 Sleep Chronobiology; 2.2 Sleep Homeostasis; 2.3 Interaction Between Circadian and Homeostatic Sleep Control; 2.4 Genetics of Circadian and Homeostatic Sleep Control; 3 Physiological Functions During Sleep; 3.1 A Physiological View of Sleep; 3.2 Sensory and Motor Functions; 3.3 Respiratory Functions; 3.4 Endocrine Functions
دانلود کتاب Drug Treatment of Sleep Disorders (Milestones in Drug Therapy)